IRIS
RAIMONDO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.298
EU - Europa 6.707
AS - Asia 4.975
SA - Sud America 2.011
AF - Africa 144
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.127
SG - Singapore 2.072
BR - Brasile 1.796
IE - Irlanda 1.597
CN - Cina 1.493
SE - Svezia 1.415
IT - Italia 799
RU - Federazione Russa 714
HK - Hong Kong 643
DE - Germania 540
UA - Ucraina 401
FI - Finlandia 302
PL - Polonia 265
VN - Vietnam 253
GB - Regno Unito 225
FR - Francia 136
IN - India 113
CA - Canada 82
BE - Belgio 76
AR - Argentina 75
AT - Austria 58
MX - Messico 55
BD - Bangladesh 49
ZA - Sudafrica 47
ID - Indonesia 45
TR - Turchia 45
IQ - Iraq 38
EC - Ecuador 34
NL - Olanda 34
ES - Italia 31
CZ - Repubblica Ceca 29
PK - Pakistan 28
JP - Giappone 27
MA - Marocco 27
UZ - Uzbekistan 27
CI - Costa d'Avorio 24
CO - Colombia 21
VE - Venezuela 21
PY - Paraguay 19
LT - Lituania 17
AE - Emirati Arabi Uniti 15
CL - Cile 15
AZ - Azerbaigian 13
BO - Bolivia 13
IL - Israele 13
IR - Iran 13
JO - Giordania 12
KE - Kenya 11
KG - Kirghizistan 11
LB - Libano 11
GR - Grecia 10
NZ - Nuova Zelanda 10
PE - Perù 10
NP - Nepal 9
OM - Oman 8
EE - Estonia 7
EG - Egitto 7
UY - Uruguay 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
KZ - Kazakistan 6
LV - Lettonia 6
JM - Giamaica 5
NO - Norvegia 5
PT - Portogallo 5
TN - Tunisia 5
AM - Armenia 4
AO - Angola 4
AU - Australia 4
BY - Bielorussia 4
BZ - Belize 4
HN - Honduras 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
AL - Albania 3
BN - Brunei Darussalam 3
DK - Danimarca 3
EU - Europa 3
GT - Guatemala 3
KW - Kuwait 3
MD - Moldavia 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CR - Costa Rica 2
HU - Ungheria 2
KR - Corea 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
PH - Filippine 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
Totale 23.136
Salva come PNG Salva come JPEG
Città #
Dublin 1.597
Ashburn 1.338
Dallas 1.319
Singapore 1.099
Chandler 1.074
Nyköping 837
Jacksonville 835
Beijing 649
Hong Kong 642
Messina 413
Ann Arbor 253
Los Angeles 247
Princeton 246
Warsaw 246
Medford 223
Moscow 201
Cambridge 188
The Dalles 187
Des Moines 178
Munich 167
São Paulo 154
Dearborn 145
Boardman 117
New York 117
Ho Chi Minh City 92
Buffalo 91
Woodbridge 85
Wilmington 81
Houston 79
Jinan 74
Brussels 72
Redondo Beach 66
Helsinki 62
San Mateo 58
Rio de Janeiro 56
Shenyang 54
Belo Horizonte 53
Hanoi 53
Nanjing 53
Brasília 51
Turku 50
Tianjin 49
Seattle 42
Nuremberg 40
Rome 39
Hebei 38
Falls Church 36
Vienna 36
Haikou 35
Pune 35
Frankfurt am Main 33
Brooklyn 31
Zhengzhou 31
Catania 28
Jakarta 28
Stockholm 28
Tokyo 27
Hyderabad 26
Orem 26
Phoenix 26
Porto Alegre 26
Santa Clara 26
Bremen 25
Abidjan 24
Chennai 24
Chicago 24
Curitiba 24
Montreal 24
San Francisco 24
Boston 23
Lancaster 23
Brno 22
Dong Ket 22
Tashkent 22
Atlanta 20
Guangzhou 20
Guarulhos 20
Nanchang 20
Ningbo 20
Amsterdam 19
Campinas 19
Hangzhou 19
Ottawa 19
Baghdad 18
Denver 18
Düsseldorf 18
Johannesburg 18
London 18
Poplar 18
Ankara 16
Mexico City 16
Changsha 15
Norwalk 15
Rosolini 15
Salvador 15
Uberlândia 15
Lanzhou 14
Avola 13
Baku 13
Haiphong 13
Totale 15.013
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 326
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 213
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 198
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 195
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 191
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 191
Atrial fibrillation in patients with cirrhosis 179
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 167
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 162
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 160
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 159
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 159
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 155
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 154
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 152
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 151
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 148
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 146
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 144
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 143
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 142
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 142
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 141
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 140
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 139
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 139
Control of cccDNA function in hepatitis B virus infection. 139
[A glance into the past ... Southern and northern blot: really superseded?] 139
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 137
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 136
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 136
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 135
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 134
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 133
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 132
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 131
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 130
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 129
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 128
Clinical virology of hepatitis B virus infection 128
A 2010 update on occult hepatitis B infection. 128
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 127
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 124
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 123
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 122
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 122
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 121
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 121
Erectile dysfunction in compensated liver cirrhosis 121
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 120
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 119
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 116
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 116
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 116
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 116
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 115
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 115
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 114
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 114
Obesity and liver cancer 114
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 114
Correlates of total homocysteine plasma concentration in type 2 diabetes 113
Mitochondrial DNA is a target of HBV integration 113
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 112
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 112
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 111
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 111
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 110
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 110
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 110
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 108
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 108
Disease progression and liver cancer in the ferroportin disease. 108
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 107
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 107
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 107
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 106
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 106
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 106
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 106
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 106
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 105
HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON 105
The changing scenario of hepatocellular carcinoma in Italy: an update 105
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 104
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 103
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 103
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 102
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 102
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 102
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 101
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 101
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 100
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 100
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 99
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 99
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 99
CHRONIC HEPATITIS IN PATIENTS WITH ACTIVE HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS COMBINED INFECTIONS - A HISTOLOGICAL STUDY 99
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 99
Pattern of macrovascular invasion in hepatocellular carcinoma 98
Totale 12.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021860 0 0 0 0 0 147 60 221 70 180 108 74
2021/20221.639 20 153 48 58 95 33 126 59 29 281 216 521
2022/20234.528 334 464 224 320 309 451 81 246 1.896 31 134 38
2023/20241.189 81 180 54 104 100 197 19 248 6 56 34 110
2024/20255.245 78 75 139 347 274 221 209 1.054 1.232 309 460 847
2025/20266.430 718 1.237 1.211 1.097 1.285 882 0 0 0 0 0 0
Totale 23.604